chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a license vocational nurse (LVN) concerning a patient who on an unspecified date was vaccinated with a dose of PNEUMOVAX (lot # 658450/1380U).  The patient fainted after receiving the dose of PNEUMOVAX.  The nurse also reported that the patient also had 102 F degrees fever with swollen arm.  The patient sought unspecified medical attention.  The patient felt better after 2.5-3 days.  No further information was provided.  This is one of several reports received from the same source.  Additional information has been requested.
First Moderna Vaccine (3/9/21) Lot 002A21A - slight brain fog after that one and achiness that started about 3/20/21 - then intense and persistent brain fog following  the second vaccine with acute onset right sided body pain - has since been diagnosed with an atypical presentation of rheumatoid arthritis - usually symmetrical - hers is only one sided - diagnosed by rheumatology
TWINRIX #1 - muscular "tics" & mild paresthesia - resolved. TWINRIX #2 pain & paresthesia followed by obvious deltoid atrophy (L) deltoid.
An initial report was received in the U.S.A. from a health care provider on 07/20/2005. An 18 year old male patient felt feverish but no temperature was taken after he had received his first does of Menactra, intramuscularly in the left deltoid. He also experienced profuse sweating. The date of vaccination and onset of reaction was not reported. He took ibupofen and the symptoms resolved.
Pt was seen for rash on arms, legs, no temp, no temp x2days with rash < 50 lesions. Dx with a mild case of varicella. disc precautions for spread with patient. no itch rash
Patient reports such a sore arm that he could not lift it for approximately 3 or 4 days after injection.
This is a spontaneous report from a contactable physician via Pfizer-sales representative. A 14-year-old female patient received TRUMENBA and unspecified dose number of HPV vaccine, both via an unspecified route of administration, on an unspecified date at a single dose for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced fatigue and dizziness/out of it on an unspecified date. The outcome of the events was unknown. Information on batch number has been requested.
Information has been received from a nurse practitioner (N.P.), for the Pregnancy Registry for GARDASIL, concerning a 23 year old female with no pertinent medical history, drug reactions or allergies who on 30-APR-2008 was vaccinated intramuscularly with a first 0.5 ml dose of GARDASIL (Lot #656372/0243U).  There was no concomitant medication.  Subsequently the patient was discovered that she was pregnant.  On 05-AUG-2008 a urine pregnancy test was performed at the office and result was positive.  Her LMP was 19-JUN-2008.  Expected date of delivery was 26-MAR-2009.  No adverse effects were reported.  The patient had office visit.  Follow-up information was received from the N.P. indicating that the patient terminated her pregnancy.  The date of the termination was not available.  No further information was provided.  Upon internal review, pregnancy termination was determined to be an other important medical event.  Additional information has been requested.
their heart being slow; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC DISORDER (their heart being slow) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (and their heart and respiratory system became really affected.) and Open heart surgery. Concurrent medical conditions included Cancer.    On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CARDIAC DISORDER (their heart being slow). At the time of the report, CARDIAC DISORDER (their heart being slow) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: slow (Low) heart being slow.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    Patient take a lot of concomitant medications for cancer.  No Concomitant and treatment medications information were not reported.  Company Comment: Very limited information regarding the event has been provided at this time. The patient's medical history of open heart surgery may be a confounding factor to the event. No further information is expected.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding the event has been provided at this time. The patient's medical history of open heart surgery may be a confounding factor to the event. No further information is expected.
Sensitivity; Vaccination site discomfort; This spontaneous case was reported by a consumer and describes the occurrence of SKIN SENSITISATION (Sensitivity) and VACCINATION SITE DISCOMFORT (Vaccination site discomfort) in an 82-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, LEVETIRACETAM (KEPPRA), VITAMINS NOS (MULTIPLE VITAMIN), ROSUVASTATIN CALCIUM (CRESTOR) and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN SENSITISATION (Sensitivity) and VACCINATION SITE DISCOMFORT (Vaccination site discomfort). At the time of the report, SKIN SENSITISATION (Sensitivity) and VACCINATION SITE DISCOMFORT (Vaccination site discomfort) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication: ICE pack     This case was linked to MOD-2021-031409.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: The outcome of the events is updated; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Very limited information regarding these events has been provided at this time. Further information has been requested.
vomiting, temperature over 101, chills, extreme body aches, vomiting stopped after 12 hours, other symptoms took longer and were slower to stop. It took 48 hours for temperature to return to normal, and body aches to stop
Dizzy; Nausea; Headache; Shaking; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 11Sep2021 at 11:00 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 08Aug2021 at 11:00 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. On 11Sep2021 at 11:15, the patient experienced dizzy, nausea, shaking and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizzy, nausea, shaking and headache was not resolved at the time of this report.
Approximately 45 minutes after the injection, I felt a  gradual tightening of my chest. I took about 6 puffs of my Albuterol inhaler over the next 45 minutes and still got no relief. The pharmacist took me back down to the clinic where I was told to then go to the ER. My blood pressure was 204/133 and my pulse was 136. The doctor determined that I was having a severe allergic reaction to the vaccine. I was given an epinephrine injection, 10mg of Decadron and 50mg of Benedryl.  I was monitored for between 3 and 4 hours in the ER before I was discharged. The doctor told me that I should not receive the second dose of the vaccine.
Patient described numbness of both legs and groin beginning 12 hours after vaccine admin. He also lost sensation to penis and was unable to have an erection for 4 days and counting.
Presented to ED on 10/24 with complaints of worsening dyspnea and peripheral cyanosis. Only recent potential provoking factor identified was receiving 3rd dose of Pfizer mRNA COVID vaccine approximately 22 days prior. Reported 10 days of LLE swelling and 5 days of worsening dyspnea on exertion. CTA chest showed nonocculsive saddle PE with extensive clot burden, cor pulmonale, and possible pulmonary infarction in RUL. Venous doppler showed acute non-occlusive DVT in the RLE. Underwent direct pulmonary thrombectomy and transcatheter thrombolysis on 10/25 with Interventional Radiology. Transferred to ICU due to acute hypoxic respiratory failure after procedure. Started therapeutic anticoagulation with Heparin IV, then transitioned to Apixaban DVT treatment dosing (10mg BID x 7 days, then 5 mg BID).
Nausea (threw up) and inability to keep food down (roughly 18 hours after) that went away roughly 24 hours later Rash on left arm at site of injection that spread to entire upper arm, treatment being antihistamines (Claritin), icing of upper arm and time, starting 36 hours after vaccine and lasting 3-5 days
pt c/o both hands tingling, numbness, white in color;has recently completed a course of steroids;PMD was notified by employee;pt notified to notify infect control;
Report of sore throat, left tonsil swelling, redness and pain with swallowing. Treatment: Cold and flu medication. Outcome: Recommend she follow-up with primary doctor and or  UC to be swabbed for strep. Does not interfere with ADLs.
He was doing some balancing exercises and tweaked his ankle. His right ankle and pain was ongoing to this point.; He was doing some balancing exercises and tweaked his ankle. His right ankle and pain was ongoing to this point.; This spontaneous case was reported by a patient family member or friend and describes the occurrence of JOINT INJURY (He was doing some balancing exercises and tweaked his ankle. His right ankle and pain was ongoing to this point.) and ARTHRALGIA (He was doing some balancing exercises and tweaked his ankle. His right ankle and pain was ongoing to this point.) in an elderly male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. AS7144B and C23415) for COVID-19 prophylaxis.     Concurrent medical conditions included Gout. Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for Gout.   On 09-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 21-Aug-2023, received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced JOINT INJURY (He was doing some balancing exercises and tweaked his ankle. His right ankle and pain was ongoing to this point.) and ARTHRALGIA (He was doing some balancing exercises and tweaked his ankle. His right ankle and pain was ongoing to this point.). At the time of the report, JOINT INJURY (He was doing some balancing exercises and tweaked his ankle. His right ankle and pain was ongoing to this point.) and ARTHRALGIA (He was doing some balancing exercises and tweaked his ankle. His right ankle and pain was ongoing to this point.) had not resolved.            Patient received his first dose of Moderna Covid-19 vaccine on 24-Jan-2021 (Lot number: 007M20A), second dose of Moderna Covid-19 vaccine on 27-Feb-2021 (lot number: 023M70A), third dose of Moderna Covid-19 vaccine on 23-Oct-2021 (lot number: 032F1A), Fourth dose of Moderna Covid-19 vaccine 13-Apr-2022 (lot number: 005M21A).  It was reported that Prior to his most recent dose yesterday he noticed his ankle did not feel great. He was doing some balancing exercises and tweaked his ankle. His right ankle and pain was ongoing to this point. He has not taken medications or treatments for his symptoms but would like to know if he could take Advil or Aloprim.
Double dose was given to a baby. Pentacel and IPOL were given to a 2 month old. Staff and Doctors will more thoroughly review any and all medications given to patients.
1. PATIENT EXPERIENCED LOW GRADE FEVER/CHILLS/SHIVERING ABOUT 2 HOURS AFTER VACCINE WAS GIVEN. 2. PATIENT REPORTED THAT THE INJECTION SITE BECAME VERY ITCHY.
Fatigue/malaise and brain fog-rating moderate (impacting work), lasting from 3:30pm 2/3. Woke up 2/4 with mild fatigue/malaise, went to work and around 11:30am fatigue went to moderate and felt moderate level of myalgias (ended work shift early). Stayed in bed the rest on 2/4; all symptoms ended/resolved upon waking at 7am 2/5.   On 2/3 apx.2pm also mild R deltoid soreness; increased to moderate soreness when waking (6:30am) on 2/4. Resolved 2/5 9am.
Patient called after having both vaccinations Fluad and Spikevax, indicating that she was driving home and experienced dizziness. She felt as if her "hair was standing on end" and was feeling "weird", but she couldn't fully describe her symptoms. She indicates that things were starting to "float". Confirmed with the patient that she was not having any signs or symptoms of an allergic reaction such as shortness of breath or tongue swelling. She ended up pulling into an urgent care clinic, for fear of driving while she feeling this way. Per patient, the clinic didn't know what to attribute her symptoms to. Patient does mention her blood pressure was high at the clinic, but no other significant symptoms. Patient states that she does suffer from panic attack but "hasn't had one in years". Patient was ensured that there were no stimulant properties within the vaccinations that could've contributed to her symptoms.
fine, raised, pinpoint, pink rash on face & trunk;some rash on arms & legs began 26JAN99;
Erythematous, indurated area in arm, non tender, warm on palpation.  Recommended cool compresses.
Developed Guillain-Barre Syndrome - progressive muscle weakness, lower extremities and upper extremities, bulbar area with failure to swallow, diplopia, aspiration pneumonia, BP 180/95. Now on ventilator, trached, bradycardia requiring pacemaker insertion. Hospitalized from 10/16/12 to current 11/2/12.
patient received a flu vaccine with a 5/8 inch needle instead of a 1 inch needle
NUMBING THROUGH THE WHOLE BODY AND TOP RIGHT SHOULDER; CHILLS; FEVER; TIREDNESS; HARD TIME BREATHING; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-APR-2021, the subject experienced hard time breathing. On 09-APR-2021, the subject experienced chills. On 09-APR-2021, the subject experienced fever. On 09-APR-2021, the subject experienced tiredness. On 10-APR-2021, the subject experienced numbing through the whole body and top right shoulder. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from numbing through the whole body and top right shoulder on 10-APR-2021, and had not recovered from chills, fever, hard time breathing, and tiredness. This report was non-serious.
About a month after the shot, I started having mild headaches and back pain that I thought was related to my menstrual cycle or either the lasting effects of pneumonia from when I had COVID earlier. I went to the ER after having sharp pains in my chest and a racing heartbeat. I still have issues with my heart and when my insurance starts, I will be finding a doctor.
Information has been received from a physician concerning a 64 year old male with no known allergy who on 07-JUL-2008 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Oka/Merck) (lot number659411/0293X) subcutaneously in the left deltoid. Concomitant therapy included LUNESTA, ATACAND, XANAX, and ZOLOFT. On 16-JUL-2008, also reported as one week after vaccination, the patient experienced a zoster like rash on trunk and back and had pain around rash. The patient was treated with antivirals. Subsequently, the patient recovered from the events. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type VZV strain or with the OKA/Merck vaccine VZV strain. On an unspecified date, the sample of the lesion was collected. The sample was taken from a vesicular cluster in right anterior chest and back. Additional information is not expected.
My symptoms lasted for roughly 16 hours. I haven't had any issues since related to my vaccine since 1/15/21
1009: appeared diaphoretic pale and faint, vomited. 1012 B/P 98/60 02 sat 97, assisted to floor, elevated lower extremities 1015 102/74, pulse 85, sitting up, states feeling better, father at side. 1030 117/73, pulse 85, sitting up in chair, no c/o AO x3 no n/v. 1036 left with father, declined further medical attention. Advised to f/u with pediatrician.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients' of unknown demographics. Patients' pertinent medical history, concurrent condition and concomitant medication were not reported. No previous drug reactions/allergies were reported. Since from 25-FEB-2016 to 01-MAR-2016, these patients were vaccinated with improperly stored doses of M-M-R II (lot# L024266 and expiry date 01-JUL-2017, lot# K005110 and expiry date 04-APR-2016) (strength, dosing details, anatomical location and route were unknown). These vaccine lots underwent temperature excursion from 25-FEB-2016 to 01-MAR-2016 and were exposed to the temperature of 10.3 degree Celsius for 108 hours. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
having a sore arm; administered both the Moderna bivalent and HPV vaccine and then she realized that she already received her booster at pharmacy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (having a sore arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administered both the Moderna bivalent and HPV vaccine and then she realized that she already received her booster at pharmacy) in a 12-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 014H22A) for COVID-19 prophylaxis.     Question:Describe relevant medical history/conditions, allergy, concomitant diseases and risk factor.Answer:Type 1 Diabetes, a few food allergies.  Previously administered products included for Drug use for unknown indication: PFIZER BIONTECH COVID-19 VACCINE on 09-Dec-2022. Past adverse reactions to the above products included No adverse reaction with PFIZER BIONTECH COVID-19 VACCINE. Concurrent medical conditions included Type 1 diabetes mellitus and Food allergy. Concomitant products included HPV VACCINE for an unknown indication.    On 15-Mar-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (having a sore arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administered both the Moderna bivalent and HPV vaccine and then she realized that she already received her booster at pharmacy). At the time of the report, PAIN IN EXTREMITY (having a sore arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administered both the Moderna bivalent and HPV vaccine and then she realized that she already received her booster at pharmacy) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments.   Patient received Vaccine in the 4 weeks prior to COVID-19 vaccine. Patient received Pfizer bivalent booster on 9Dec2022. The reporter stated her daughter had her annual well visit and she was told she is due for the COVID booster. They administered both the Moderna bivalent and HPV vaccine and then she realized that she already received her booster at pharmacy but Dr didn't knew it. She Asked Doctor if there was problem but she didn't hear back from Doctor. Reporter daughter reported to had sore arm No treatment information was reported.
Small Right Side Pontine Stroke confirmed by CT and MRI. Treatment includes statin, and anti-platelet med.   Symptoms: Left sided hemiparesis up to 85% loss of function for 10 days with small improvments over days/weeks.
Pfizer 8/2/21, 8/23/21. Positive on 8/8/22
Information has been received from two physicians concerning a 4 year old male (birth date reported as 30-APR-2002 and 20-APR-2002) with no known allergies or pertinent medical history who on 19-MAY-2003 at one year of age, was vaccinated in the left thigh with a dose of Varivax (lot # 644091/1066M). There was no concomitant medication. On 30-DEC-2006 (also reported as 03-JAN-2007) the patient developed a zoster like rash on the lower left leg and another rash above the lower left buttock (the rash was also described as vesicular and developed on the left side from the midline of the back, down the left buttock and down the left crossing numerous dermatomes) (the physician was unsure if this was zoster). Medical attention was sought, a pediatrician (not the reporting physician) was seen on day 6 or 7 of the rash, the rash was described as "getting better", and the patient was treated with acyclovir. It was also reported that the patient was referred to a dermatologist and zoster was diagnosed. On approximately 05-JAN-2007 testing was done and the patient had a negative varicella IgM titer, and a varicella anticomplement immunogluorescence (ACIF) was greater than 1/2256. The patient's immune system was evaluated and found to be "normal." On 11-JAN-2007 the patient was considered recovered when examined by the dermatologist. There was no product quality complaint involved. No further information was provided. Additional information has been requested.